SCHEMBL7744041

SCHEMBL7744041

CCCCC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1c(Cl)cccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TSHR P16473 2/20 0.46
USP2 O75604 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDR P35968 5/20 0.45
FLT1 P17948 1/20 0.45
FLT4 P35916 1/20 0.45
ADORA1 P30542 3/20 0.43
HSP90AA1 P07900 2/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
ADORA3 P0DMS8 1/20 0.41
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744162 0.93 KDR (0.45) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7739022 0.90 KDR (0.54) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7744192 0.90 KDR (0.51) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7744659 0.90 KDR (0.50) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7744054 0.89 MEN1 (0.42) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7746639 0.85 KDR (0.61) HPGDSMN1; SMN2TSHRKDRFLT1
SCHEMBL7744044 0.85 HPGD (0.44) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7739007 0.85 KDR (0.51) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7744651 0.84 HPGD (0.51) HPGDSMN1; SMN2TSHRUSP2NPSR1
SCHEMBL7744672 0.84 HPN (0.42) HPGDSMN1; SMN2TSHRUSP2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed